← All diseases Blood and bone marrow

Myelodysplastic syndrome

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest level of evidence only (47)Meta-analysis (14)Treatment guideline (3)Systematic review (10)Randomized trial (10)Phase 3 study (10)Clinical trial (605)Review article (239)Early study (phase 1 or 2) (47)Description of individual patients (223)Laboratory or animal studies (12)Commentary or editorial (67) Only studies currently recruiting participants (42)

Filter

Publications and studies (1773)

• Serum Inflamma-miR Signature: A Biomarker of Myelodysplastic Syndrome? (2020/11/20) ♡
• Transcriptomic analysis of patients with immune thrombocytopenia treated with eltrombopag. (2020/11/16) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Concordant acute myeloblastic leukemia in identical twins treated with allogeneic transplantation from a younger HLA-identical sibling following a single apheresis procedure. (2020/11/16) ♡
• Simplified flow cytometry scoring for diagnosis and prognosis of myelodysplastic syndrome. (2020/11/15) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Myelodysplastic syndrome with chromosome 5q deletion and Philadelphia chromosome: case report and literature review]. (2020/11/14) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Vitamin B(12) deficiency influences increased formation of ring sideroblasts in pre-myelodysplastic syndromes. (2020/11/01) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. C3 inhibition with pegcetacoplan in subjects with paroxysmal nocturnal hemoglobinuria treated with eculizumab. (2020/11/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Chronic myeloid leukaemia after chemoradiotherapy for solid malignancies. (2020/11/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Unmet Supportive Care Needs of Patients with Hematological Malignancies: A Systematic Review. (2020/10/15) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. The geriatric nutritional risk index predicts the early death and survival in patients with myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes treated with azacitidine. (2020/10/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. From functions to mechanisms of the prototypic complement C5 antibody BB5.1. (2020/10/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Thrombocytopenia and platelet transfusion in myelodysplastic syndromes. (2020/10/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Many signs, one mutation: Early onset of de novo GATA2 deficiency syndrome. A case report. (2020/09/30) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. BK virus-induced nephritis and cystitis after matched unrelated donor stem cell transplantation: A case report. (2020/09/07) ♡
• Cytogenetic and cytokine profile in elderly patients with cytopenia. (2020/09/01) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. [Results of phase Ib open multicenter clinical trial of the safety, pharmacokinetics and pharmacodynamics of first biosimilar of eculizumab in untreated patients with paroxysmal nocturnal hemoglobinuria during induction of therapy]. (2020/09/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Transitory response of a myelodysplastic syndrome with deletion of chromosome 5q to thalidomide. Report of one case. (2020/09/01) ♡
• Highlights in myelodysplastic syndromes from the 2020 American Society of Clinical Oncology Annual Meeting and the 25th European Hematology Association Congress. (2020/09/01) ♡
• Highlights in myelodysplastic syndromes from the 2020 American Society of Clinical Oncology Annual Meeting and the 25th European Hematology Association Congress: commentary. (2020/09/01) ♡
• A Prospective, Cross Sectional Study of PNH Clone in MDS Patients Using High Sensitivity Flowcytometry: A Single Center Experience. (2020/07/01) ♡
• FLAER Based Assay According to Newer Guidelines Increases Sensitivity of PNH Clone Detection. (2020/07/01) ♡
• SETD2 deficiency accelerates MDS-associated leukemogenesis via S100a9 in NHD13 mice and predicts poor prognosis in MDS. (2020/06/18) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Myelodysplastic syndromes and the risk of cardiovascular disease in older adults: A SEER-Medicare analysis. (2020/06/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Tolerability and Efficacy of Treatment With Azacytidine as Prophylactic or Preemptive Therapy for Myeloid Neoplasms After Allogeneic Stem Cell Transplantation. (2020/06/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Oligo-monocytic CMML and other pre-CMML states: Clinical impact, prognostication and management. (2020/06/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Myelodysplastic/myeloproliferative neoplasm, unclassifiable (MDS/MPN-U): More than just a "catch-all" term? (2020/06/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Myelodysplastic/myeloproliferative neoplasms - Justified inclusion as unique biological entities. (2020/06/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Atypical CML- the role of morphology and precision genomics. (2020/06/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes - Advances in treatment. (2020/06/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Autoimmune disease in CMML-the chicken or the egg? (2020/06/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Myelodysplastic/myeloproliferative neoplasms: are morphology and immunophenotyping still relevant? (2020/06/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Strain-resolved microbiome sequencing reveals mobile elements that drive bacterial competition on a clinical timescale. (2020/05/29) ♡
• An MDS-specific frailty index based on cumulative deficits adds independent prognostic information to clinical prognostic scoring. (2020/05/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Hypomethylating agent based combinations in higher risk myelodysplastic syndrome. (2020/05/01) ♡
• Hypomethylating agent (HMA) therapy use and survival in older adults with Refractory Anemia with Excess Blasts (RAEB) in the United States (USA): a large propensity score-matched population-based study(†). (2020/05/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Clonal dynamics of aplastic anemia/paroxysmal nocturnal hemoglobinuria. (2020/05/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Impact of transfusion on survival in patients with myelodysplastic syndromes: Current knowledge, new insights and transfusion clinical practice. (2020/05/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Secondary Pulmonary Alveolar Proteinosis Following Treatment with Azacitidine for Myelodysplastic Syndrome. (2020/04/15) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Knowledge of Secondary Pulmonary Alveolar Proteinosis Complicated with Myelodysplastic Syndrome. (2020/04/15) ♡
• Downregulation of microRNA-144 inhibits proliferation and promotes the apoptosis of myelodysplastic syndrome cells through the activation of the AKAP12-dependent ERK1/2 signaling pathway. (2020/04/01) ♡
• Combining gene variants with clinical characteristics improves outcome prediction in Chinese patients with myelodysplastic syndromes. (2020/04/01) ♡
• Changes in heparan sulfate sulfotransferases and cell-surface heparan sulfate during SKM-1 cells granulocytic differentiation and A549 cells epithelial-mesenchymal transition. (2020/04/01) ♡
• Clinical impact of dysplastic changes in acquired aplastic anemia: A systematic study of bone marrow biopsies in children and adults. (2020/04/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Novel Prognostic Models for Myelodysplastic Syndromes. (2020/04/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Targeting Aberrant Splicing in Myelodysplastic Syndromes: Biologic Rationale and Clinical Opportunity. (2020/04/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Targeting TP53 Mutations in Myelodysplastic Syndromes. (2020/04/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Prospects for Venetoclax in Myelodysplastic Syndromes. (2020/04/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Assessing Symptom Burden in Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Patients. (2020/04/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. The hematological effects of copper deficiency. (2020/04/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Cytokine receptor splice variants in hematologic diseases. (2020/03/01) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.